March 08, 2023
Moderna has responded to arguments from a former top federal judge, among other legal academics and pharmaceutical trade organizations that are weighing in on a billion-dollar patent lawsuit over the ownership of the mRNA platform behind one of the COVID-19 vaccines, by asking a federal judge in Delaware to disregard those arguments entirely.
March 03, 2023
The Biden administration's position that the government should be the target of a billion-dollar patent suit over Moderna's COVID-19 vaccine in federal claims court has been decried by that court's former top judge and other officials, who say that approach flouts patent law.
February 14, 2023
The U.S. government urged a Delaware federal judge on Tuesday to toss claims accusing Moderna Inc. of infringing the patents of a rival mRNA developer with its COVID-19 vaccine, saying that because the vaccine was developed for the government, the claims can only target the government.
November 02, 2022
Moderna Inc. must continue to fight claims that it infringed the patents of a rival mRNA developer with its COVID-19 vaccine, a Delaware federal judge ruled Wednesday in finding Moderna can't yet establish that the vaccine was developed specifically "for the government," thus shielding it from the litigation.
June 06, 2022
Two companies suing Moderna Inc. in Delaware federal court for patent infringement over its widely used COVID-19 vaccine have slammed the drugmaker's attempt to toss part of the case, saying the government cannot act as a shield from paying damages.
May 06, 2022
Moderna Inc. on Friday urged a Delaware federal court to throw out a lawsuit accusing it of infringing the patents of a rival mRNA developer with its COVID-19 vaccine, arguing that the claims should be filed against the federal government, not Moderna.
February 28, 2022
Moderna was hit with a suit on Monday that accused it of earning "billions in profits" by selling COVID-19 vaccines that infringed the patents of a rival mRNA developer.